Open · RFA-FD-25-020 · CFDA 93.103 · Discretionary

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.

up to $900K
Award range
Open
Status
613d
Days left
-
Expected awards

The verdict

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required) is an open discretionary opportunity from Food and Drug Administration, offering Up to $900,000. Applications close in 613 days. PlainGrants indexes 481 other opportunities from Food and Drug Administration.

up to $900K
award range
Open
613 days left
93.103
CFDA program
481
other opportunities from Food and Drug Administration

Open desk with published close date

Reissue of RFA-FD-23-001- Clinical Studies of… remains open until May 16, 2028 (613 days out). Award range Up to $900,000 without a cost-share requirement. Parent CFDA 93.103 may carry future cycles if this NOFO closes unfunded.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

613 days left to apply

Posted Jul 11 → closes May 16, 2028

Posted Jul 11 Closes May 16

Instrument

Grant

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.

Catch-all / unrestricted eligibility mark · RFA-FD-25-020

Grants.gov marks Reissue of RFA-FD-23-001- Clinical Studies of… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity codes span Agriculture · Consumer Protection · Food and Nutrition (AG;CP;FN). 119 other Food and Drug Administration listings share this eligibility-code string (25% of 482).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Patrick Johnson Grants Management Specialist

What to do next

Reissue of RFA-FD-23-001- Clinical Studies of… is open with Up to $900,000 awards and 613 days left on the clock.

  • Submit through Grants.gov (RFA-FD-25-020) - verify SAM.gov registration and the current NOFO before drafting. Official listing
  • Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
  • Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants